Ionis (IONS): Oversold, Levered, and Poised for a Bounce — The Heartbreak Is Priced In
Ionis trades well below its 50-day trend after a tough stretch, but strong sector growth for oligonucleotides, an outsized short book, and deeply oversold technicals set up a disciplined long swing. Fundamentals require respect - negative cash flow and heavy leverage - so keep position sizing tight and a firm stop.